Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL3916909 | 0.95 | FDPS (0.31) | FDPS | |
| Hydrochloric Acid SCHEMBL3942008 | 0.95 | FDPS (0.31) | FDPS | |
| Iodide SCHEMBL3933597 | 0.75 | — | — | |
| Bromide SCHEMBL3941430 | 0.75 | — | — | |
| SCHEMBL30869354 | 0.70 | FDPS (0.31) | FDPS | |
| Bromide SCHEMBL3941662 | 0.70 | — | — | |
| SCHEMBL18209246 | 0.62 | FDPS (0.46) | FDPS | |
| SCHEMBL26005314 | 0.60 | FDPS (0.50) | FDPS | |
| 1-Methylimidazole SCHEMBL3009509 | 0.57 | — | — | |
| 1-Methylimidazole SCHEMBL30779766 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044169-A1 | USE OF PT- AND PD-BIS- AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | BASF SE (DE) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008000726-A1 | USE OF PT- AND PD-BIS- AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | BASF SE (DE) | 2008-01-03 | — | — | WO | disclosed |